Chris Senanayake

Board Member at Shuttle Pharmaceuticals

Dr. Senanayake was appointed to the position of Director on the Company's Board of Directors and a Scientific Advisor in 2020 with over +30 years of pharmaceutical industry experience. He received his PhD in Synthetic Organic Chemistry in 1987. Currently, he is the Founder and Chief Executive Officer (CEO) of TCG GreenChem Inc. and Chief Scientific Officer of TCG Lifesciences, Pvt. Ltd. From 1989-1996, he held positions of Senior Scientist at Dow Chemical, and Research Fellow at Merck & Co, Inc. From 1996 to 2002, he served as Director and Executive Director of Process Research at Sepracor, Inc. and from 2002 to 2018 as Director of Chemical Development and Vice President of Chemical Development for Boehringer Ingelheim Pharmaceuticals, Inc. In 2018 -2019, he was appointed as the CEO of Asta GreenChem, Inc in Richmond VA and Astatech (Chengdu) Biopharmaceuticals Corp. in China. He has a record of leading and delivering on high complexity APIs for manufacturing. Dr. Senanayake participated in many drugs development activities including multi-billion-dollar blockbuster drugs, Crixivan, Lunesta, Jardiance, R, R Formotorol, Desvenlafaxine, HCV arena and many other drug candidates which now improve the lives of millions of patients worldwide. He is co-author of 425 scientific publications and is co-inventor of >150 patents.